U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705412) titled 'Postoperative Radiotherapy and Lymph Node Dissection After Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma' on July 11.
Brief Summary: This is a multicenter, retrospective observational study using existing medical records of patients with esophageal squamous cell carcinoma who received at least two cycles of neoadjuvant immunochemotherapy followed by curative surgery with complete tumor removal and negative surgical margins between January 2021 and December 2024.
The main aim of this study is to evaluate whether postoperative radiotherapy is associated with better control of cancer recurrence in the surgical ...